Question 2

Heparin is included in the ISMP high-alert list in acute care.

Antithrombotic agents, such as heparin, are recognized as high-alert medications by the ISMP due to their significant potential for causing harm when used inappropriately. These medications require special safeguards to reduce the risk of errors associated with their use.

A) heparin.

Heparin is an anticoagulant that is critical in preventing and treating thromboembolic disorders, making it a key component of the ISMP high-alert list in acute care settings. Its narrow therapeutic range and the consequences of dosing errors underscore the importance of heightened awareness and safety measures when it is administered.

B) amitriptyline.

Amitriptyline is a tricyclic antidepressant primarily used for depression and certain types of pain management. It is not classified as an antithrombotic agent and does not belong on the ISMP high-alert list for acute care, as its risks are not aligned with those associated with anticoagulants.

C) itraconazole.

Itraconazole is an antifungal medication used to treat various fungal infections. Like amitriptyline, it does not fit the definition of an antithrombotic agent and is not designated as a high-alert medication in the context of acute care.

D) pioglitazone.

Pioglitazone is an antidiabetic medication used to improve glycemic control in patients with type 2 diabetes. It does not have anticoagulant properties and is therefore not included in the ISMP high-alert list for antithrombotic agents in acute care settings.

Conclusion

Heparin is the only option listed that qualifies as an antithrombotic agent and is recognized as a high-alert medication due to the risks associated with its use. The other options, amitriptyline, itraconazole, and pioglitazone, do not share these characteristics and are not included in the ISMP high-alert list, emphasizing the unique safety concerns surrounding anticoagulants like heparin.